generic injectable drugs

 

Published April 2017  ·  Report No. JBD735F · Price US $1,850

 


In terms of the number of unique products, drugs formulated and supplied for administration via injection represent the second largest dosage form market segment. The market for injectable generics has been expanding rapidly as a wave  of patents covering this drug class have expired. As the market continues to evolve, opportunities for shrewd product planners are likely to appear briefly in the all-out rush to gain advantage in the marketplace.  This publication is designed to identify and highlight APIs and indications in ways that allow decision makers to refine and optimize their generic drug strategies.

 

 

Report Brochure (Download PDF)

 

Report Order Form (Download PDF)

 


Generic Injectable Drugs – Content Highlights

  • Provides detailed analysis of generic drugs developed, formulated and supplied for administration via injection
  • Presents the competitive picture for generic injectable drugs.
  • Evaluates the importance of ANDA filing strategies and indirect ANDA acquisition on participant growth prospects
  • Analyzes the impact of patents, exclusivity and litigation on participant market sector prospects
  • Assesses the market presence and product position of the top generic injectables drug suppliers

Generic Injectable Drugs – Summary of Contents

 

Generic Markets Overview

Major Market Segments for Generic Drugs

FDA Approved Generic Drugs by Therapeutic Class

Growth in Injectables

Demand Drivers

Evolving ANDA Filing Strategies

The Secondary Market for Buying/Selling ANDAs

 

Competitive Landscape

Generic Injectables Market Analysis

Drug Class Analysis

Adrenergic Agents

Anabolic Agents

Antibiotics

Anesthetics

Antiarrhythmics

Anticoagulants

Anticonvulsants

Antiemetics

Anti-inflammatory

Antihypertensives

Antineoplastics

Antivirals

Diuretics

Folic Acid Metabolites

Growth Hormone Inhibitors

Muscle Relaxants

Narcotic Analgesics

Neurotransmitter

Opioid Antagonist

Sedatives

Vasodilators

 

Therapeutic Class Analysis

Antiinfectives

Cardiology

Hematology

Neurology

Pain Management

Other Key Classes

 

Company Analysis

Key Generic Drug Opportunity Factors

Saturation Index

API Opportunity Index

P(iv) Injectable Drug Index

Orange Book Injectable Drug Patent Staircase Analysis